Read why lawyers think the healthcare mandate might have the best chance at surviving Supreme Court review. Solicitor General Elizabeth Prelogar and her top deputy, Brian Fletcher, will represent the federal government. Louisiana solicitor Elizabeth Murrill and Missouri’s Jesus Osete will take on the healthcare vaccination rule. Lehotsky Keller’s Scott Keller will argue for a coalition of business groups against the large-employer mandate. The challengers in both cases contend the U.S. The other mandate applies to a majority of the estimated 10.3 million Americans who work in healthcare facilities. The large employer rule would require businesses with more than 100 employees to be vaccinated or tested weekly. The cases are the first tests of the federal government's authority to issue its own vaccine mandates, our colleague Lawrence Hurley reports. Supreme Court this morning will hear from six lawyers in two cases contesting the Biden administration’s power to mandate COVID-19 vaccinations for large businesses and healthcare workers. Our Standards: The Thomson Reuters Trust Principles.The U.S. Wait what? FDA wants 55 years to process FOIA request over vaccine data 'Paramount importance': Judge orders FDA to hasten release of Pfizer vaccine docs 4:21-cv-01058.įor plaintiff: Aaron Siri of Siri & Glimstad and John Howie of Howie Lawįor FDA: Courtney Enlow of the U.S. District Court for the Northern District of Texas, No.
The case is Public Health and Medical Professionals for Transparency v. The attorneys also said they would not oppose Pfizer's intervention if the company's "involvement is limited to prevent delay or prejudice." The plaintiffs said in their filing that Pfizer could help the FDA without intervening in the lawsuit. The company's filing said it was not aware of the lawsuit before reading news media reports about it. In its filing, Pfizer said the company supports public disclosure of FDA records "to promote transparency and the public's confidence in the vaccine." Siri & Glimstad, the New York boutique firm that filed the lawsuit, has fought mandatory vaccination efforts. The FDA earlier drew criticism over its plan to release 500 pages a month in response to the lawsuit from Public Health and Medical Professionals for Transparency, a production schedule that would take more than 50 years to complete. The FDA declined to comment on Wednesday, and Pfizer said in a statement that its intervention "will help accelerate the release of documents." 6 order that directed the agency to release 55,000 pages monthly starting on March 1. The judge is also expected to take up the FDA's logistical concerns about his Jan. Pittman scheduled a hearing for Friday to consider Pfizer's bid to intervene. The FDA said on Tuesday in its court filing that it welcomed the opportunity to coordinate with Pfizer amid what the agency called the "unusual and indeed extraordinary circumstances" of the case. government agencies control the release of information under federal public-records laws, but companies can challenge and even sue to block the disclosure of certain details. On Tuesday night, the group of doctors and scientists who sued last year over public access to the FDA's Pfizer licensing records said in a court filing that the company's bid to jump into the lawsuit was untimely because the plaintiffs have not challenged any redactions to requested records.Įarlier this month, the judge ordered a fast-track release of hundreds of thousands of documents, calling the case "of paramount public importance." 21 it wanted a role in the proceedings to help the FDA avoid "inappropriately" disclosing trade secret and confidential commercial information. Food and Drug Administration used in licensing the company's COVID-19 vaccine, a litigation move that plaintiffs who are suing for the data say is premature. (Reuters) - Pfizer Inc wants to intervene in a Texas federal lawsuit seeking information from the U.S. Plaintiffs contend Pfizer's bid in Texas federal court is untimely.Drug company wants to protect any trade secrets, business proprietary information.
0 kommentar(er)
